NunaBio Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $8.73M

  • Investors
  • 14

NunaBio General Information

Description

Manufacturer of synthetic genetic material designed for the rapid production of high-complexity DNA constructs. The company's technology utilizes cell-free enzymatic manufacturing and modular micro-foundries to produce synthetic DNA constructs, long deoxyribonucleic acid products, short deoxyribonucleic acid products, DNA biosensors, consumables, and oligonucleotides, enabling biotechnology organizations to access scalable genetic material for the development of vaccines and gene therapies.

Contact Information

Website
www.nunabio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • The Biosphere Draymans Way
  • Newcastle Helix
  • Newcastle Upon Tyne NE4 5BX
  • England, United Kingdom
+44 0330
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • The Biosphere Draymans Way
  • Newcastle Helix
  • Newcastle Upon Tyne NE4 5BX
  • England, United Kingdom
+44 0330

NunaBio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NunaBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 30-Apr-2026 $8.73M Completed Generating Revenue
6. Later Stage VC 16-Sep-2024 Completed Generating Revenue
5. Accelerator/Incubator 13-Dec-2023 Completed Generating Revenue
4. Seed Round 02-May-2023 Completed Generating Revenue
3. Seed Round 04-Apr-2021 Completed Generating Revenue
2. Grant 01-Apr-2021 $415K Completed Generating Revenue
1. University Spin-Out 01-Jun-2012 Completed Generating Revenue
To view NunaBio’s complete valuation and funding history, request access »

NunaBio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary
Ordinary
A Ordinary
Ordinary 111,674 $0.013431 $7.21 $7.21 1x $7.21 8.88%
Ordinary 59,600 $0.013431 $4.51 $4.51 1x $4.51 4.74%
To view NunaBio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

NunaBio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of synthetic genetic material designed for the rapid production of high-complexity DNA constructs. The comp
Discovery Tools (Healthcare)
Newcastle Upon Tyne, United Kingdom
21 As of 2026

Poway, CA
 

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NunaBio Competitors (88)

One of NunaBio’s 88 competitors is ProSci (Biotechnology), a Private Equity-Backed company based in Poway, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ProSci (Biotechnology) Private Equity-Backed Poway, CA
Basecamp Research Venture Capital-Backed London, United Kingdom
Integrated DNA Technologies Formerly PE-Backed Coralville, IA
Twist Bioscience Formerly VC-backed South San Francisco, CA
Adaptyv Venture Capital-Backed Lausanne, Switzerland
You’re viewing 5 of 88 competitors. Get the full list »

NunaBio Patents

NunaBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202412718-D0 Junction regions, templates and method for nucleic acid synthesis Pending 30-Aug-2024
GB-2644434-A Junction regions, templates and methods for nucleic acid synthesis Pending 30-Aug-2024
WO-2026047131-A1 Templates and methods for nucleic acid synthesis Pending 30-Aug-2024
GB-2638211-A A nucleic acid assembly method using type iib enzymes Pending 15-Feb-2024
WO-2025172578-A1 A nucleic acid assembly method using type iib enzymes Pending 15-Feb-2024 C12N15/10
To view NunaBio’s complete patent history, request access »

NunaBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NunaBio Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ascension Ventures Corporate Venture Capital Minority
HIT Investments Asset Manager Minority
Mason Capital Corporation Minority
EMV Capital Venture Capital Minority
North East Fund Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

NunaBio FAQs

  • When was NunaBio founded?

    NunaBio was founded in 2012.

  • Where is NunaBio headquartered?

    NunaBio is headquartered in Newcastle Upon Tyne, United Kingdom.

  • What is the size of NunaBio?

    NunaBio has 21 total employees.

  • What industry is NunaBio in?

    NunaBio’s primary industry is Discovery Tools (Healthcare).

  • Is NunaBio a private or public company?

    NunaBio is a Private company.

  • What is the current valuation of NunaBio?

    The current valuation of NunaBio is .

  • What is NunaBio’s current revenue?

    The current revenue for NunaBio is .

  • How much funding has NunaBio raised over time?

    NunaBio has raised $12.4M.

  • Who are NunaBio’s investors?

    Ascension Ventures, HIT Investments, Mason Capital, EMV Capital, and North East Fund are 5 of 14 investors who have invested in NunaBio.

  • Who are NunaBio’s competitors?

    ProSci (Biotechnology), Basecamp Research, Integrated DNA Technologies, Twist Bioscience, and Adaptyv are some of the 88 competitors of NunaBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process